Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors
Edgewise Therapeutics, Inc. (EWTX)
Company Research
Source: Business Wire
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced the appointment of biotechnology industry veteran Arlene Morris to its Board of Directors. Ms. Morris has extensive experience in the pharmaceutical and biotechnology industries serving in numerous executive management and board roles.“With over 30 years of exceptional leadership experience in the biotech industry, we are delighted to welcome Arlene to our Board,” said Kevin Koch, Ph.D., President and Chief Executive Officer. “Arlene brings invaluable expertise in strategic development and operational excellence, and we are thankful to count her as a valued advisor as we continue to advance our mission of changing the lives of patients and families affected by serious muscle diseases.”Ms. Morris currently serves as Chief Executive Officer of Willow Advisors, a consultancy advising biotech companies on financing, strategy and business dev
Show less
Read more
Impact Snapshot
Event Time:
EWTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EWTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EWTX alerts
High impacting Edgewise Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
EWTX
News
- Edgewise: Intriguing Drug Candidate, But Consider Selling After Recent Run [Seeking Alpha]Seeking Alpha
- Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024 [Yahoo! Finance]Yahoo! Finance
- Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024Business Wire
- Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsBusiness Wire
EWTX
Earnings
- 5/9/24 - Beat
EWTX
Sec Filings
- 5/10/24 - Form 8-K
- 5/10/24 - Form S-3ASR
- 5/9/24 - Form S-8
- EWTX's page on the SEC website